Press Releases

Revive Therapeutics Reports Grant of Options
/ August 14, 2026 / Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF)(CSE:RVV)(Frankfurt:31R), a life sciences company focused on the research and development of therapeutics for biodefence and pandemic prep...
August 14, 2026 at 6:52 PM